Veterinary Medicines

Pneumovac Plus Suspension for Injection for Cattle

Authorised
  • Bovine respiratory syncytial virus, strain BIO-24, Inactivated
  • Bovine parainfluenza virus 3, strain BIO-23, Inactivated
  • Mannheimia haemolytica, serotype A1, strain DSM 5283, Inactivated
  • Bovine viral diarrhoea virus, strain BIO-25, Inactivated
Download as PDF

Product identification

Medicine name:
Pneumovac Plus suspension for injection for cattle
Pneumovac Plus Suspension for Injection for Cattle
Active substance:
  • Bovine respiratory syncytial virus, strain BIO-24, Inactivated
  • Bovine parainfluenza virus 3, strain BIO-23, Inactivated
  • Mannheimia haemolytica, serotype A1, strain DSM 5283, Inactivated
  • Bovine viral diarrhoea virus, strain BIO-25, Inactivated
Target species:
  • Cattle
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Bovine respiratory syncytial virus, strain BIO-24, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
  • Bovine parainfluenza virus 3, strain BIO-23, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
  • Mannheimia haemolytica, serotype A1, strain DSM 5283, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
  • Bovine viral diarrhoea virus, strain BIO-25, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AL04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • United Kingdom (Northern Ireland)
Package description:
  • The vaccine is filled in glass vials:Hydrolytic type I 10ml vials containing 10 ml (5 doses). All containers are closed with chlorobutyl rubber stoppers and secured with aluminium seals. The product is delivered as follows: 10 x 10ml in a transparent plastic box with cover. Carton for mass packaging 10 x 10 mlEach package contains an approved Package Leaflet
  • The vaccine is filled in glass vials:100ml vials containing 100 ml (50 doses). All containers are closed with chlorobutyl rubber stoppers and secured with aluminium seals. The product is delivered as follows:1 x 100ml in cardboard boxes. Each package contains an approved Package Leaflet.
  • The vaccine is filled in glass vials:Hydrolytic type I 50ml vials containing 50 ml (25 doses). All containers are closed with chlorobutyl rubber stoppers and secured with aluminium seals. The product is delivered as follows:1 x 50ml in cardboard boxes. Each package contains an approved Package Leaflet.
  • The vaccine is filled in glass vials:Hydrolytic type I 10ml vials containing 10 ml (5 doses). All containers are closed with chlorobutyl rubber stoppers and secured with aluminium seals. The product is delivered as follows:1 x 10ml in cardboard boxes. Each package contains an approved Package Leaflet.
  • In plastic vials:15ml vials containing 10 ml (5 doses)All containers are closed with chlorobutyl rubber stoppers and secured with aluminium seals.The product is delivered as follows:1 x 10ml in cardboard boxesEach package contains an approved Package Leaflet
  • In plastic vials:60ml vials containing 50ml (25 doses)All containers are closed with chlorobutyl rubber stoppers and secured with aluminium seals.The product is delivered as follows:1 x 50ml in cardboard boxesEach package contains an approved Package Leaflet
  • In plastic vials:120ml vials containing 100ml (50 doses)All containers are closed with chlorobutyl rubber stoppers and secured with aluminium seals.The product is delivered as follows:1 x 100ml in cardboard boxesEach package contains an approved Package Leaflet
  • In plastic vials:15ml vials containing 10 ml (5 doses)All containers are closed with chlorobutyl rubber stoppers and secured with aluminium seals.The product is delivered as follows: 10 x 10ml in a transparent plastic box with cover. Carton for mass packaging 10 x 10 mlEach package contains an approved Package Leaflet

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Animal Health Distributors Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • The Veterinary Medicines Directorate
Authorisation number:
  • Vm 51609/4001
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0639/001
Concerned member states:
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."